10th European AIDS Conference (EACS), 17-20 November 2005, Dublin, Ireland
11 February 2006. Related: Conference reports, Conference index, EACS 10 Dublin 2005.
- Rifaximin cure reported for cryptosporidium in advanced HIV
- Analysis of hepatic events in 2NN study by CD4 entry criteria, levels differences between nevirapine and efavirenz; excess hepatic events in once-daily nevirapine arm linked to single site in Thailand
- FTC studies at EACS: reduced incidence of M184V compared to 3TC; side effect profile in clinical practice
- Paediatric studies at EACS: trends in antiretroviral use in the Madrid Cohort; life expectancy significantly increased HIV/HCV co-infected children since HAART; use of tenofovir in treatment experienced children; switching to lopinavir/r from double protease inhibitor regimen; once daily lopinavir/r, 3TC and abacavir; planned treatment interruptions in children
- Efficacy of lopinavir/r in patients with advanced HIV (CD4 <25 cells/mm3)
- Potential barriers to use of T-20: results from patient and physician interviews
- Factors associated with sexual dysfunction in HIV patients
- Decreased varicella zoster immunity in migrants from sub-Saharan Africa
- Clinical experience of switching to atazanavir in the UKs largest clinic
- Replacing a PI with atazanavir: separating swans from ducklings?
- TMC 125: some good and bad news
- When to change a failing regimen: second-line and salvage strategies
- Antiretrovirals and other stuff!
- Heart disease in people with HIV
- Mortality trends: why people with HIV die (or dont) today
The conference organisers have not yet published abstracts from the meeting online, although they will go online.
[Note: abstracts have since been posted to the EACS abstract archive: http://www.abstractserver.com/eacsabstractarchive]
However, webcasts of several of the presentations are included, though free registration is required, and access is not instant:
10th EUROPEAN AIDS CONFERENCE / EACS
http://www.eacs-conference2005.com
The following subjects are covered in the reports from this conference:
- Rifaximin cure reported for cryptosporidium
- Analysis of hepatic events in 2NN study
- Efficacy of lopinavir/r in patients with advanced HIV
- Potential barriers to use of T-20
- FTC studies at EACS
- Paediatric studies at EACS
- Factors associated with sexual dysfunction in HIV patients
- Decreased varicella zoster immunity in migrants from sub-Saharan Africa
- Clinical experience of switching to atazanavir
- TMC 125: some good and bad news
- Second-line and salvage strategies
- Antiretrovirals and other stuff!
- Heart disease in people with HIV
- Mortality trends: why people with HIV die (or dont) today